A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma
Clinical trial NCT04936529 · RECRUITING
Trial details
- NCT number
- NCT04936529
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-02
- Primary completion
- 2027-06-15
- Enrollment
- 286
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.